US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Innoviva

18.46

-0.0800-0.43%

Post-market: 18.460.00000.00%18:36 EDT

Volume:474.99K

Turnover:8.79M

Market Cap:1.16B

PE:-19.35

High:18.72

Open:18.55

Low:18.36

Close:18.54

Loading ...

Overview Company News Filings

HC Wainwright Initiates Innoviva at Buy With $40 Price Target

MT Newswires Live

Innoviva Initiated at Buy by HC Wainwright & Co.

Innoviva Initiated at Overweight by Cantor Fitzgerald

Armata Pharmaceuticals Inc. Conducted Annual Shareholders Meeting

FDA Grants Priority Review for Innoviva's Zoliflodacin, Aiming to Introduce First New Gonorrhea Antibiotic in Decades by December 2025

FDA Grants Priority Review for Zoliflodacin New Drug Application for the Treatment of Uncomplicated Gonorrhea and Assigns Target Pdufa Date of December 15, 2025

THOMSON REUTERS

Innoviva Inc. Announces FDA Acceptance of New Drug Application for Zoliflodacin, Paving Way for New Gonorrhea Treatment

Innoviva Specialty Therapeutics Receives FDA New Drug Application Acceptance for Zoliflodacin, a First-in-Class Oral Antibiotic for Uncomplicated Gonorrhea in Adults

THOMSON REUTERS

Innoviva Inc. to Participate in Goldman Sachs 46th Annual Global Healthcare Conference 2025

Innoviva Elects Board Members and Approves Compensation

Innoviva Inc. Conducted Annual Stockholders Meeting, Electing Five Board Members

BRIEF-ZEVTERA(Ceftobiprole), An Advanced-Generation Cephalosporin Antibiotic Now Commercially Available In The U.S. To Treat Three Types Of Bacterial Infections

Zevtera® (Ceftobiprole), an Advanced-Generation Cephalosporin Antibiotic NOW Commercially Available in the U.S. to Treat Three Types of Bacterial Infections

THOMSON REUTERS

Armata Pharmaceuticals Announces Positive Topline Data from Phase 1b/2a diSArm Trial of AP-SA02 for Staphylococcus aureus Bacteremia

Armata Pharmaceuticals Reports Q1 2025 Net Loss of $6.5M, Improvement from $25M Loss in 2024; EPS Loss Narrows to $0.18

Innoviva Inc reports results for the quarter ended March 31 - Earnings Summary

Innoviva Q1 EPS $(0.74) Misses $0.38 Estimate, Sales $88.63M Beat $82.67M Estimate

BRIEF-Innoviva Q1 Royalty Revenue USD 57.807 Million

Armata Pharmaceuticals Secures Additional $4.65 Million Non-Dilutive Funding from U.S. Department of Defense to Support Ongoing Clinical Trial of AP-SA02

Health Rounds: Appendectomy appears to reduce ulcerative colitis relapses

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/INVA/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"INVA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INVA\",,,,,undefined,":{"symbol":"INVA","market":"US","secType":"STK","nameCN":"Innoviva","latestPrice":18.46,"timestamp":1753819200000,"preClose":18.54,"halted":0,"volume":474986,"hourTrading":{"tag":"盘后","latestPrice":18.46,"preClose":18.46,"latestTime":"18:36 EDT","volume":22928,"amount":423252.46,"timestamp":1753828570013},"delay":0,"floatShares":57606014,"shares":62775173,"eps":-0.95395,"marketStatus":"Not Yet Opened","change":-0.08,"latestTime":"07-29 16:00:00 EDT","open":18.55,"high":18.72,"low":18.36,"amount":8789014.301528,"amplitude":0.019417,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.95395,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1753862400000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":18.54,"dividendRate":0.000054,"preHourTrading":{"tag":"盘前","latestPrice":18.35,"preClose":18.54,"latestTime":"09:07 EDT","volume":2,"amount":36.7,"timestamp":1753794421523},"postHourTrading":{"tag":"盘后","latestPrice":18.46,"preClose":18.46,"latestTime":"18:36 EDT","volume":22928,"amount":423252.46,"timestamp":1753828570013},"volumeRatio":0.67167,"impliedVol":0.143,"impliedVolPercentile":0.072},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INVA\",,,,,undefined,":{"symbol":"INVA","floatShares":57606014,"roa":"9.40%","roe":"-8.84%","lyrEps":0.372923,"volumeRatio":0.67167,"shares":62775173,"dividePrice":0.001,"high":18.72,"amplitude":0.019417,"preClose":18.54,"low":18.36,"week52Low":16.67,"pbRate":"1.79","psRate":"3.13","week52High":22,"institutionHeld":0.6682,"latestPrice":18.46,"eps":-0.95395,"divideRate":0.000054,"volume":474986,"delay":0,"ttmEps":-0.95395,"open":18.55,"prevYearClose":17.35,"prevWeekClose":18.72,"prevMonthClose":20.09,"prevQuarterClose":20.09,"fiveDayClose":19.28,"twentyDayClose":20.09,"sixtyDayClose":18.65},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"INVA\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2551819081","title":"HC Wainwright Initiates Innoviva at Buy With $40 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2551819081","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551819081?lang=en_us&edition=fundamental","pubTime":"2025-07-14 21:11","pubTimestamp":1752498692,"startTime":"0","endTime":"0","summary":"HC Wainwright Initiates Innoviva at Buy With $40 Price Target","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["INVA"],"gpt_icon":0},{"id":"2551518359","title":"Innoviva Initiated at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2551518359","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551518359?lang=en_us&edition=fundamental","pubTime":"2025-07-14 19:04","pubTimestamp":1752491040,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/INVA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  July 14, 2025 07:04 ET (11:04 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INVA","BK4007"],"gpt_icon":0},{"id":"2550736953","title":"Innoviva Initiated at Overweight by Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2550736953","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550736953?lang=en_us&edition=fundamental","pubTime":"2025-07-11 20:12","pubTimestamp":1752235920,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/INVA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  July 11, 2025 08:12 ET (12:12 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INVA"],"gpt_icon":0},{"id":"2543563713","title":"Armata Pharmaceuticals Inc. Conducted Annual Shareholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2543563713","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543563713?lang=en_us&edition=fundamental","pubTime":"2025-06-14 04:05","pubTimestamp":1749845159,"startTime":"0","endTime":"0","summary":"Armata Pharmaceuticals Inc. held its Annual Meeting of Shareholders on June 12, 2025. During the meeting, shareholders elected seven members to the board of directors. Additionally, the compensation of the company's named executive officers was approved on a non-binding advisory basis. Shareholders also ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025. All proposals presented at the meeting were approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Armata Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securiti","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250613:nNDLbHDNpF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","INVA","BK4139","ARMP"],"gpt_icon":0},{"id":"2542351530","title":"FDA Grants Priority Review for Innoviva's Zoliflodacin, Aiming to Introduce First New Gonorrhea Antibiotic in Decades by December 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2542351530","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542351530?lang=en_us&edition=fundamental","pubTime":"2025-06-12 19:00","pubTimestamp":1749726031,"startTime":"0","endTime":"0","summary":"FDA Grants Priority Review for Innoviva's Zoliflodacin, Aiming to Introduce First New Gonorrhea Antibiotic in Decades by December 2025. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Innoviva Inc. published the original content used to generate this news brief via Business Wire  on June 12, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250612:nNDL79CNxW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","INVA"],"gpt_icon":0},{"id":"2542513049","title":"FDA Grants Priority Review for Zoliflodacin New Drug Application for the Treatment of Uncomplicated Gonorrhea and Assigns Target Pdufa Date of December 15, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2542513049","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542513049?lang=en_us&edition=fundamental","pubTime":"2025-06-12 19:00","pubTimestamp":1749726000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250612:nTUA7VFYF3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","INVA"],"gpt_icon":0},{"id":"2542339041","title":"Innoviva Inc. Announces FDA Acceptance of New Drug Application for Zoliflodacin, Paving Way for New Gonorrhea Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2542339041","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542339041?lang=en_us&edition=fundamental","pubTime":"2025-06-10 18:00","pubTimestamp":1749549629,"startTime":"0","endTime":"0","summary":"Innoviva Specialty Therapeutics, a subsidiary of Innoviva Inc., has announced that the U.S. Food and Drug Administration  has accepted the New Drug Application  for zoliflodacin, marking a significant milestone in the regulatory review process. Zoliflodacin is a first-in-class oral antibiotic aimed at treating uncomplicated gonorrhea in adults, including infections caused by multidrug-resistant strains. The acceptance of the NDA represents a crucial step forward in addressing the growing threat of drug-resistant gonorrhea, a public health concern that has been exacerbated by recent cases of ceftriaxone-resistant infections. If approved, zoliflodacin would be the first new antibiotic treatment for gonorrhea in decades. The Global Antibiotic Research Development Partnership  also plays a vital role in this initiative, highlighting the importance of public-private partnerships in combating global antimicrobial resistance.Disclaimer: This news brief was created by Public Technologies  usin","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250610:nNDL1Wks6z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0820561818.USD","LU2112291526.USD","LU1244550577.SGD","LU1934455194.USD","LU1430594728.SGD","LU0029864427.USD","LU1929549753.HKD","SG9999015986.USD","LU1839511570.USD","LU1093756168.USD","INVA","LU0256863811.USD","IE0009355771.USD","LU1732799900.SGD","LU0949170772.SGD","SG9999011175.SGD","LU2237443978.SGD","LU0965509101.SGD","LU0203345920.USD","ABBV","IE00BDGV0183.EUR","LU1934455277.USD","LU2237443382.USD","IE00B3PB1722.GBP","LU0861579265.USD","LU1718418525.SGD","LU2129689605.HKD","LU2237443549.SGD","LU1162221912.USD","BK4139","LU0170899867.USD","IE0002141913.USD","BK4533","SG9999003800.SGD","LU0965509010.AUD","LU1983299246.USD","BK4566","LU0122379950.USD","LU1074936037.SGD","LU1496350502.SGD","LU1551013425.SGD","LU1989771016.USD","LU0689472784.USD","IE00B19Z3B42.SGD","LU0820561909.HKD","IE00BVYPNW00.USD","BK4588","LU0234570918.USD","BK4585","LU1244550221.USD"],"gpt_icon":0},{"id":"2542909933","title":"Innoviva Specialty Therapeutics Receives FDA New Drug Application Acceptance for Zoliflodacin, a First-in-Class Oral Antibiotic for Uncomplicated Gonorrhea in Adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2542909933","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542909933?lang=en_us&edition=fundamental","pubTime":"2025-06-10 18:00","pubTimestamp":1749549600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250610:nTUA2VB2KY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["INVA","BK4007"],"gpt_icon":0},{"id":"2540775916","title":"Innoviva Inc. to Participate in Goldman Sachs 46th Annual Global Healthcare Conference 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2540775916","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540775916?lang=en_us&edition=fundamental","pubTime":"2025-06-03 19:00","pubTimestamp":1748948417,"startTime":"0","endTime":"0","summary":"Innoviva Inc., a diversified holding company with a focus on royalties, critical care, and infectious disease platforms, is set to participate in the Goldman Sachs 46th Annual Global Healthcare Conference 2025. The event will take place on Monday, June 9, 2025, at 1:20 p.m. Eastern Time, featuring a fireside chat. A live webcast will be accessible through the Investor Relations section of Innoviva's website, with an archived replay available post-presentation.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Innoviva Inc. published the original content used to generate this news brief via Business Wire  on June 03, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250603:nNDL2TMR1F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1894683348.USD","LU1791807156.HKD","LU2237443465.HKD","BK4585","LU1868837136.USD","IE00B19Z3581.USD","LU1868836757.USD","IE0034235188.USD","LU2471134796.USD","LU2750360997.AUD","LU0106831901.USD","LU2471134523.USD","IE0002270589.USD","IE00B19Z3B42.SGD","BK4007","BK4533","IE0004086264.USD","LU0096364046.USD","BK4552","IE0004091025.USD","LU0048573561.USD","LU2237443978.SGD","BK4588","LU1894683264.USD","LU1868836914.USD","IE00BSNM7G36.USD","LU1868837300.USD","BK4550","LU1668664300.SGD","LU2237443895.HKD","LU2471134952.CNY","LU0251131958.USD","IE00BFXG1179.USD","LU0742534661.SGD","INVA","LU2237438978.USD","BK4516","LU0251142724.SGD","LU2237443622.USD","BK4504","LU1868836591.USD","LU2237443382.USD","LU2471134879.HKD","LU2237443549.SGD","BK4127","LU2750360641.GBP","LU0061475181.USD"],"gpt_icon":0},{"id":"2537093951","title":"Innoviva Elects Board Members and Approves Compensation","url":"https://stock-news.laohu8.com/highlight/detail?id=2537093951","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537093951?lang=en_us&edition=fundamental","pubTime":"2025-05-22 04:56","pubTimestamp":1747860993,"startTime":"0","endTime":"0","summary":"Innoviva ( ($INVA) ) just unveiled an update. At the Annual Meeting of Stockholders on May 19, 2025, Innoviva, Inc. elected five board members for ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/innoviva-elects-board-members-and-approves-compensation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/innoviva-elects-board-members-and-approves-compensation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INVA","BK4007"],"gpt_icon":0},{"id":"2537959646","title":"Innoviva Inc. Conducted Annual Stockholders Meeting, Electing Five Board Members","url":"https://stock-news.laohu8.com/highlight/detail?id=2537959646","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537959646?lang=en_us&edition=fundamental","pubTime":"2025-05-22 04:16","pubTimestamp":1747858602,"startTime":"0","endTime":"0","summary":"Innoviva Inc. held its Annual Meeting of Stockholders on May 19, 2025. During the meeting, five members were elected to the board of directors. Stockholders approved Innoviva's executive compensation on a non-binding advisory basis. Additionally, the selection of Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Innoviva Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 21, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250521:nNDL8qn6ZJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INVA","BK4007"],"gpt_icon":0},{"id":"2536615589","title":"BRIEF-ZEVTERA(Ceftobiprole), An Advanced-Generation Cephalosporin Antibiotic Now Commercially Available In The U.S. To Treat Three Types Of Bacterial Infections","url":"https://stock-news.laohu8.com/highlight/detail?id=2536615589","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536615589?lang=en_us&edition=fundamental","pubTime":"2025-05-20 18:08","pubTimestamp":1747735738,"startTime":"0","endTime":"0","summary":"BRIEF-ZEVTERA(Ceftobiprole), An Advanced-Generation Cephalosporin Antibiotic Now Commercially Available In The U.S. To Treat Three Types Of Bacterial InfectionsMay 20 (Reuters) - Innoviva Inc INVA.O:Z","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250520:nFWN3RR32B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INVA","BK4007"],"gpt_icon":0},{"id":"2536613782","title":"Zevtera® (Ceftobiprole), an Advanced-Generation Cephalosporin Antibiotic NOW Commercially Available in the U.S. to Treat Three Types of Bacterial Infections","url":"https://stock-news.laohu8.com/highlight/detail?id=2536613782","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536613782?lang=en_us&edition=fundamental","pubTime":"2025-05-20 18:04","pubTimestamp":1747735478,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250520:nFWN3RR32B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["INVA","BK4007"],"gpt_icon":0},{"id":"2536968581","title":"Armata Pharmaceuticals Announces Positive Topline Data from Phase 1b/2a diSArm Trial of AP-SA02 for Staphylococcus aureus Bacteremia","url":"https://stock-news.laohu8.com/highlight/detail?id=2536968581","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536968581?lang=en_us&edition=fundamental","pubTime":"2025-05-19 19:01","pubTimestamp":1747652475,"startTime":"0","endTime":"0","summary":"Armata Pharmaceuticals Announces Positive Topline Data from Phase 1b/2a diSArm Trial of AP-SA02 for Staphylococcus aureus Bacteremia. LOS ANGELES, May 19, 2025/PRNewswire/ -- Armata Pharmaceuticals, Inc. , a clinical-stage biotechnology company, announced positive topline results from its Phase 1b/2a diSArm trial. The study evaluated AP-SA02, an intravenous multi-phage therapeutic, for the treatment of Staphylococcus aureus bacteremia in the intent-to-treat population. The trial, a multicenter, randomized, double-blind, placebo-controlled study, assessed the safety, tolerability, and efficacy of AP-SA02 in addition to best available antibiotic therapy versus antibiotic therapy alone. No treatment-related serious adverse events were observed. Armata has developed a proprietary manufacturing process capable of producing over 10,000 full courses of phage therapy annually at its California facility. The company plans to move towards a pivotal trial to further evaluate AP-SA02.Disclaimer: T","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250519:nNDL6kkCSM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","INVA","BK4139","ARMP"],"gpt_icon":0},{"id":"2535007343","title":"Armata Pharmaceuticals Reports Q1 2025 Net Loss of $6.5M, Improvement from $25M Loss in 2024; EPS Loss Narrows to $0.18","url":"https://stock-news.laohu8.com/highlight/detail?id=2535007343","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535007343?lang=en_us&edition=fundamental","pubTime":"2025-05-15 04:09","pubTimestamp":1747253345,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Armata Pharmaceuticals Inc. published the original content used to generate this news brief via PR Newswire  on May 14, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nNDL7LSg0k:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARMP","INVA"],"gpt_icon":0},{"id":"2533606899","title":"Innoviva Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2533606899","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533606899?lang=en_us&edition=fundamental","pubTime":"2025-05-08 05:33","pubTimestamp":1746653612,"startTime":"0","endTime":"0","summary":"Innoviva Inc reports results for the quarter ended March 31 - Earnings SummaryInnoviva Inc INVA.OQ reported a quarterly adjusted loss of 74 cents per share for the quarter ended March 31, lower than t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250507:nL8N3RF3CJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INVA"],"gpt_icon":0},{"id":"2533962810","title":"Innoviva Q1 EPS $(0.74) Misses $0.38 Estimate, Sales $88.63M Beat $82.67M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2533962810","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533962810?lang=en_us&edition=fundamental","pubTime":"2025-05-08 04:52","pubTimestamp":1746651145,"startTime":"0","endTime":"0","summary":"Innoviva (NASDAQ:INVA) reported quarterly losses of $(0.74) per share which missed the analyst consensus estimate of $0.38 by 294.74 percent. This is a 260.87 percent decrease over earnings of $0.46 per share from the","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45268917/innoviva-q1-eps-0-74-misses-0-38-estimate-sales-88-63m-beat-82-67m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INVA"],"gpt_icon":0},{"id":"2533966127","title":"BRIEF-Innoviva Q1 Royalty Revenue USD 57.807 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2533966127","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533966127?lang=en_us&edition=fundamental","pubTime":"2025-05-08 04:05","pubTimestamp":1746648347,"startTime":"0","endTime":"0","summary":"BRIEF-Innoviva Q1 Royalty Revenue USD 57.807 Million\n\n\nMay 07 (Reuters) - Innoviva Q1 pretax profit USD -38.589 million.\n\nQ1 net income USD -46.584 million","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250507:nPLX03295D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INVA"],"gpt_icon":0},{"id":"2532307506","title":"Armata Pharmaceuticals Secures Additional $4.65 Million Non-Dilutive Funding from U.S. Department of Defense to Support Ongoing Clinical Trial of AP-SA02","url":"https://stock-news.laohu8.com/highlight/detail?id=2532307506","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532307506?lang=en_us&edition=fundamental","pubTime":"2025-05-01 19:00","pubTimestamp":1746097255,"startTime":"0","endTime":"0","summary":"Armata Pharmaceuticals Secures Additional $4.65 Million Non-Dilutive Funding from U.S. Department of Defense to Support Ongoing Clinical Trial of AP-SA02. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Armata Pharmaceuticals Inc. published the original content used to generate this news brief via PR Newswire  on May 01, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250501:nNDL6FWHCz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARMP","BK4007","INVA","BK4139"],"gpt_icon":0},{"id":"2527400424","title":"Health Rounds: Appendectomy appears to reduce ulcerative colitis relapses","url":"https://stock-news.laohu8.com/highlight/detail?id=2527400424","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527400424?lang=en_us&edition=fundamental","pubTime":"2025-04-16 03:31","pubTimestamp":1744745505,"startTime":"0","endTime":"0","summary":"Health Rounds: Appendectomy appears to reduce ulcerative colitis relapsesHealth Rounds is published on Tuesdays and Thursdays. Think your friend or colleague should know about us?Forward this newsletter to them. They can also subscribe hereBy Nancy LapidApril 15  - Hello Health Rounds Readers!","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250415:nL2N3QO11H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK5011","LU0971552830.HKD","LU0225284248.USD","LU1228905540.USD","LU1400636574.HKD","LU0203345920.USD","IE00BQJZX424.USD","LU1302929846.USD","LU0321505439.SGD","LU1670756490.USD","LU0225771236.USD","LU0985481810.HKD","LU1035777561.USD","INVA","IE00BWDBJ516.SGD","LU1228905037.USD","LU1400636657.SGD","LU1487256676.USD","LU1046248800.SGD","LU0289739699.SGD","LU1064927863.SGD","GSK.UK","LU0109981661.USD","LU0971552673.USD","IE0034235071.USD","LU1202635105.USD","LU0306807586.USD","LU0545562505.USD","LU1481600234.SGD","LU1015430645.USD","LU0575583348.USD","LU1645745479.HKD","BK4007","LU1481599808.USD","LU0058720904.USD","LU0203347892.USD","LU1098665638.USD","LU0211331839.USD","LU0306806265.USD","LU1400636491.USD","LU0321505868.SGD"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":35,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/INVA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-07","symbol":"INVA","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746590400000,"reportTimeType":"post","actualEps":0.25},{"market":"US","date":"2025-02-26","symbol":"INVA","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1740546000000,"reportTimeType":"post","actualEps":0.57},{"market":"US","date":"2024-11-06","symbol":"INVA","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730869200000,"reportTimeType":"post","actualEps":0.02},{"market":"US","date":"2024-07-31","symbol":"INVA","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1722398400000,"reportTimeType":"post","actualEps":0.68},{"market":"US","date":"2024-05-08","symbol":"INVA","fiscalQuarterEnding":"2024/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715140800000,"reportTimeType":"post","actualEps":0.46}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"INVA\",market:\"US\",,,undefined,":[{"executeDate":"2015-09-08","recordDate":"2015-09-10","paymentDate":"2015-09-30","value":0.25,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"INVA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":3,"updateTime":1752552000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/INVA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"INVA","date":"2025-07-28","current":-19.676365,"percent":0.03786,"low":-22.913716,"twenty":3.690731,"median":5.250308,"eighty":9.247889,"high":50.287764,"avg":7.420449,"sd":11.110402,"marketCap":1175151238},"quantilePoints":[{"date":"2020-07-31","current":6.022481,"twenty":-19.3028,"median":3.549437,"eighty":9.734772,"marketCap":1373360477},{"date":"2020-08-07","current":6.006919,"twenty":-19.3028,"median":3.56806,"eighty":9.734772,"marketCap":1369811742},{"date":"2020-08-14","current":6.207001,"twenty":-19.3028,"median":3.574064,"eighty":9.734772,"marketCap":1415438336},{"date":"2020-08-21","current":5.660109,"twenty":-19.3028,"median":3.580793,"eighty":9.734772,"marketCap":1290725646},{"date":"2020-08-28","current":5.184358,"twenty":-19.3028,"median":3.590897,"eighty":9.734772,"marketCap":1182235745},{"date":"2020-09-04","current":5.131002,"twenty":-19.3028,"median":3.597376,"eighty":9.734772,"marketCap":1170068653},{"date":"2020-09-11","current":5.099878,"twenty":-19.3028,"median":3.603966,"eighty":9.734772,"marketCap":1162971183},{"date":"2020-09-18","current":5.142118,"twenty":-19.3028,"median":3.610307,"eighty":9.734772,"marketCap":1172603464},{"date":"2020-09-25","current":4.7753,"twenty":-19.3028,"median":3.624143,"eighty":9.734772,"marketCap":1088954708},{"date":"2020-10-02","current":4.544094,"twenty":-19.3028,"median":3.638518,"eighty":9.734772,"marketCap":1036230644},{"date":"2020-10-09","current":4.633019,"twenty":-19.3028,"median":3.650886,"eighty":9.734772,"marketCap":1056509131},{"date":"2020-10-16","current":4.419598,"twenty":-19.3028,"median":3.657517,"eighty":9.734772,"marketCap":1007840764},{"date":"2020-10-23","current":4.54854,"twenty":-19.3028,"median":3.680202,"eighty":9.734772,"marketCap":1037244569},{"date":"2020-10-30","current":5.063773,"twenty":-19.3028,"median":3.692734,"eighty":9.734772,"marketCap":1096043563},{"date":"2020-11-06","current":4.76866,"twenty":-19.3028,"median":3.70442,"eighty":9.734772,"marketCap":1032166834},{"date":"2020-11-13","current":5.166829,"twenty":-19.3028,"median":3.721325,"eighty":9.734772,"marketCap":1118349723},{"date":"2020-11-20","current":5.129354,"twenty":-19.3028,"median":3.7446,"eighty":9.734772,"marketCap":1110238392},{"date":"2020-11-27","current":5.08251,"twenty":-19.3028,"median":3.757137,"eighty":9.734772,"marketCap":1100099228},{"date":"2020-12-04","current":4.923243,"twenty":-19.3028,"median":3.765619,"eighty":9.734772,"marketCap":1065626073},{"date":"2020-12-11","current":4.820187,"twenty":-19.3028,"median":3.785487,"eighty":9.734772,"marketCap":1043319913},{"date":"2020-12-18","current":5.846058,"twenty":-19.3028,"median":3.794822,"eighty":9.734772,"marketCap":1265367592},{"date":"2020-12-24","current":5.780477,"twenty":-19.3028,"median":3.815326,"eighty":9.734772,"marketCap":1251172763},{"date":"2020-12-31","current":5.803899,"twenty":-19.3028,"median":3.825988,"eighty":9.734772,"marketCap":1256242345},{"date":"2021-01-08","current":6.028747,"twenty":-19.3028,"median":3.856729,"eighty":9.734772,"marketCap":1304910329},{"date":"2021-01-15","current":5.958482,"twenty":-19.3028,"median":3.88134,"eighty":9.734772,"marketCap":1289701584},{"date":"2021-01-22","current":5.780477,"twenty":-19.3028,"median":3.91509,"eighty":9.734772,"marketCap":1251172763},{"date":"2021-01-29","current":5.625894,"twenty":-19.3028,"median":3.977452,"eighty":9.734772,"marketCap":1217713524},{"date":"2021-02-05","current":5.616251,"twenty":-19.3028,"median":4.196332,"eighty":9.734772,"marketCap":1260298010},{"date":"2021-02-12","current":5.467147,"twenty":-19.3028,"median":4.388474,"eighty":9.734772,"marketCap":1226838771},{"date":"2021-02-19","current":5.304488,"twenty":-19.3028,"median":4.524085,"eighty":9.734772,"marketCap":1190337783},{"date":"2021-02-26","current":5.16446,"twenty":-19.3028,"median":4.606342,"eighty":9.734772,"marketCap":1158915097},{"date":"2021-03-05","current":5.200606,"twenty":-19.350738,"median":4.699714,"eighty":9.735579,"marketCap":1167026489},{"date":"2021-03-12","current":5.440078,"twenty":-19.350738,"median":4.7753,"eighty":9.735579,"marketCap":1220764459},{"date":"2021-03-19","current":5.539482,"twenty":-19.350738,"median":4.824209,"eighty":9.735579,"marketCap":1243070787},{"date":"2021-03-26","current":5.38134,"twenty":-19.3028,"median":4.895137,"eighty":9.734772,"marketCap":1207583448},{"date":"2021-04-01","current":5.403932,"twenty":-19.3028,"median":4.934954,"eighty":9.734772,"marketCap":1212653068},{"date":"2021-04-09","current":5.287269,"twenty":-19.350738,"median":4.974771,"eighty":9.735579,"marketCap":1186473740},{"date":"2021-04-16","current":5.37765,"twenty":-19.350738,"median":5.002877,"eighty":9.735579,"marketCap":1206755342},{"date":"2021-04-23","current":5.287269,"twenty":-19.350738,"median":5.035667,"eighty":9.735579,"marketCap":1186473740},{"date":"2021-04-30","current":4.587818,"twenty":-19.350738,"median":5.063773,"eighty":9.735579,"marketCap":1161121737},{"date":"2021-05-07","current":4.700009,"twenty":-19.350738,"median":5.063773,"eighty":9.735579,"marketCap":1189515980},{"date":"2021-05-14","current":5.156788,"twenty":-19.350738,"median":5.069575,"eighty":9.735579,"marketCap":1305121114},{"date":"2021-05-21","current":5.276993,"twenty":-19.350738,"median":5.089537,"eighty":9.735579,"marketCap":1335543518},{"date":"2021-05-28","current":5.389184,"twenty":-19.350738,"median":5.131002,"eighty":9.735579,"marketCap":1363937761},{"date":"2021-06-04","current":5.200863,"twenty":-19.350738,"median":5.156788,"eighty":9.735579,"marketCap":1316275995},{"date":"2021-06-11","current":5.048603,"twenty":-19.350738,"median":5.156788,"eighty":9.735579,"marketCap":1277740951},{"date":"2021-06-18","current":5.341102,"twenty":-19.350738,"median":5.162126,"eighty":9.735579,"marketCap":1351768799},{"date":"2021-06-25","current":5.409218,"twenty":-19.350738,"median":5.180882,"eighty":9.735579,"marketCap":1369008162},{"date":"2021-07-02","current":5.465314,"twenty":-19.350738,"median":5.188804,"eighty":9.735579,"marketCap":1383205283},{"date":"2021-07-09","current":5.393191,"twenty":-19.350738,"median":5.206589,"eighty":9.735579,"marketCap":1364951841},{"date":"2021-07-16","current":5.232918,"twenty":-19.350738,"median":5.232918,"eighty":9.735579,"marketCap":1324388636},{"date":"2021-07-23","current":5.353122,"twenty":-19.350738,"median":5.254827,"eighty":9.735579,"marketCap":1354811040},{"date":"2021-07-30","current":3.715923,"twenty":-19.350738,"median":5.264972,"eighty":9.735579,"marketCap":985433172},{"date":"2021-08-06","current":4.04087,"twenty":-6.072838,"median":5.264972,"eighty":9.735579,"marketCap":1071606454},{"date":"2021-08-13","current":4.295062,"twenty":2.761506,"median":5.264972,"eighty":9.735579,"marketCap":1139016198},{"date":"2021-08-20","current":4.177138,"twenty":2.806003,"median":5.264972,"eighty":9.735579,"marketCap":1107743637},{"date":"2021-08-27","current":3.84695,"twenty":2.834874,"median":5.264972,"eighty":9.735579,"marketCap":1020180463},{"date":"2021-09-03","current":4.025147,"twenty":2.881226,"median":5.264972,"eighty":9.735579,"marketCap":1067436779},{"date":"2021-09-10","current":4.069696,"twenty":2.891291,"median":5.264972,"eighty":9.735579,"marketCap":1079250858},{"date":"2021-09-17","current":4.101143,"twenty":2.905594,"median":5.264972,"eighty":9.735579,"marketCap":1087590208},{"date":"2021-09-24","current":4.240031,"twenty":2.941086,"median":5.264972,"eighty":9.735579,"marketCap":1124422336},{"date":"2021-10-01","current":4.460156,"twenty":2.973399,"median":5.264972,"eighty":9.735579,"marketCap":1182797785},{"date":"2021-10-08","current":4.420848,"twenty":3.003594,"median":5.264972,"eighty":9.735579,"marketCap":1172373598},{"date":"2021-10-15","current":4.352714,"twenty":3.022236,"median":5.264972,"eighty":9.735579,"marketCap":1154305007},{"date":"2021-10-22","current":4.255754,"twenty":3.039616,"median":5.264972,"eighty":9.735579,"marketCap":1128592011},{"date":"2021-10-29","current":3.919172,"twenty":3.063454,"median":5.264972,"eighty":9.735579,"marketCap":1212638907},{"date":"2021-11-05","current":4.06965,"twenty":3.078287,"median":5.264972,"eighty":9.735579,"marketCap":1259198682},{"date":"2021-11-12","current":3.988796,"twenty":3.144504,"median":5.264972,"eighty":9.735579,"marketCap":1234181489},{"date":"2021-11-19","current":3.829334,"twenty":3.278956,"median":5.264972,"eighty":9.735579,"marketCap":1184842027},{"date":"2021-11-26","current":3.800137,"twenty":3.310817,"median":5.264972,"eighty":9.735579,"marketCap":1175808040},{"date":"2021-12-03","current":3.674364,"twenty":3.366978,"median":5.264972,"eighty":9.735579,"marketCap":1136892408},{"date":"2021-12-10","current":3.690086,"twenty":3.399379,"median":5.264972,"eighty":9.735579,"marketCap":1141756862},{"date":"2021-12-17","current":3.910188,"twenty":3.434335,"median":5.264972,"eighty":9.735579,"marketCap":1209859219},{"date":"2021-12-23","current":3.950615,"twenty":3.463967,"median":5.264972,"eighty":9.735579,"marketCap":1222367815},{"date":"2021-12-31","current":3.874253,"twenty":3.495501,"median":5.264972,"eighty":9.735579,"marketCap":1198740467},{"date":"2022-01-07","current":3.930402,"twenty":3.516963,"median":5.260304,"eighty":9.734772,"marketCap":1216113517},{"date":"2022-01-14","current":3.766448,"twenty":3.526683,"median":5.260304,"eighty":9.734772,"marketCap":1165384210},{"date":"2022-01-21","current":3.631691,"twenty":3.530182,"median":5.260304,"eighty":9.734772,"marketCap":1123688890},{"date":"2022-01-28","current":3.600248,"twenty":3.537296,"median":5.260304,"eighty":9.734772,"marketCap":1113959982},{"date":"2022-02-04","current":3.512656,"twenty":3.548507,"median":5.260304,"eighty":9.734772,"marketCap":1086858023},{"date":"2022-02-11","current":5.031803,"twenty":3.560719,"median":5.260304,"eighty":9.734772,"marketCap":1337724869},{"date":"2022-02-18","current":5.225233,"twenty":3.568459,"median":5.269342,"eighty":9.734772,"marketCap":1389149097},{"date":"2022-02-25","current":5.065784,"twenty":3.574833,"median":5.269342,"eighty":9.734772,"marketCap":1346758855},{"date":"2022-03-04","current":4.513774,"twenty":3.582107,"median":5.269342,"eighty":9.734772,"marketCap":1200004892},{"date":"2022-03-11","current":4.937676,"twenty":3.590711,"median":5.269342,"eighty":9.734772,"marketCap":1312701003},{"date":"2022-03-18","current":4.971693,"twenty":3.59574,"median":5.269342,"eighty":9.734772,"marketCap":1321744519},{"date":"2022-03-25","current":5.126864,"twenty":3.60143,"median":5.269342,"eighty":9.734772,"marketCap":1362997424},{"date":"2022-04-01","current":5.166121,"twenty":3.609038,"median":5.269342,"eighty":9.734772,"marketCap":1373433852},{"date":"2022-04-08","current":5.20276,"twenty":3.621043,"median":5.269342,"eighty":9.734772,"marketCap":1383174518},{"date":"2022-04-14","current":4.980308,"twenty":3.626567,"median":5.269342,"eighty":9.734772,"marketCap":1324034762},{"date":"2022-04-22","current":4.666258,"twenty":3.63727,"median":5.269342,"eighty":9.734772,"marketCap":1240543342},{"date":"2022-04-29","current":6.33037,"twenty":3.649123,"median":5.279209,"eighty":9.734772,"marketCap":1186969681},{"date":"2022-05-06","current":5.731887,"twenty":3.654188,"median":5.29302,"eighty":9.734772,"marketCap":1074751826},{"date":"2022-05-13","current":5.895443,"twenty":3.660684,"median":5.306767,"eighty":9.734772,"marketCap":1105419193},{"date":"2022-05-20","current":6.055282,"twenty":3.684861,"median":5.317914,"eighty":9.734772,"marketCap":1135389574},{"date":"2022-05-27","current":5.746756,"twenty":3.690175,"median":5.332028,"eighty":9.734772,"marketCap":1077539768},{"date":"2022-06-03","current":5.698433,"twenty":3.692734,"median":5.341102,"eighty":9.734772,"marketCap":1068478955},{"date":"2022-06-10","current":5.512574,"twenty":3.702116,"median":5.365506,"eighty":9.734772,"marketCap":1033629674},{"date":"2022-06-17","current":5.493988,"twenty":3.715796,"median":5.371587,"eighty":9.734772,"marketCap":1030144746},{"date":"2022-06-24","current":5.486554,"twenty":3.727935,"median":5.373157,"eighty":9.735579,"marketCap":1028750775},{"date":"2022-07-01","current":5.534877,"twenty":3.748483,"median":5.389184,"eighty":9.735579,"marketCap":1037811588},{"date":"2022-07-08","current":5.382473,"twenty":3.755218,"median":5.393191,"eighty":9.735579,"marketCap":1009235177},{"date":"2022-07-15","current":5.352735,"twenty":3.760182,"median":5.393191,"eighty":9.735579,"marketCap":1003659292},{"date":"2022-07-22","current":5.41221,"twenty":3.770133,"median":5.409218,"eighty":9.735579,"marketCap":1014811062},{"date":"2022-07-29","current":10.046571,"twenty":3.785487,"median":5.413225,"eighty":9.758835,"marketCap":999583566},{"date":"2022-08-05","current":10.116631,"twenty":3.795068,"median":5.425245,"eighty":9.818411,"marketCap":1006554163},{"date":"2022-08-12","current":10.32681,"twenty":3.796195,"median":5.429252,"eighty":9.840354,"marketCap":1027465953},{"date":"2022-08-19","current":9.892439,"twenty":3.796195,"median":5.429252,"eighty":9.840354,"marketCap":984248254},{"date":"2022-08-26","current":9.338967,"twenty":3.796195,"median":5.429252,"eighty":9.775415,"marketCap":929180540},{"date":"2022-09-02","current":9.163818,"twenty":3.796195,"median":5.429252,"eighty":9.732367,"marketCap":911754048},{"date":"2022-09-09","current":9.268907,"twenty":3.796195,"median":5.429252,"eighty":9.707338,"marketCap":922209943},{"date":"2022-09-16","current":8.757471,"twenty":3.796195,"median":5.429252,"eighty":9.630338,"marketCap":871324587},{"date":"2022-09-23","current":8.267053,"twenty":3.796195,"median":5.429252,"eighty":9.579714,"marketCap":822530410},{"date":"2022-09-30","current":8.133939,"twenty":3.796195,"median":5.429252,"eighty":9.553725,"marketCap":809286276},{"date":"2022-10-07","current":8.687411,"twenty":3.796195,"median":5.429252,"eighty":9.509074,"marketCap":864353990},{"date":"2022-10-14","current":9.268907,"twenty":3.796195,"median":5.429252,"eighty":9.481881,"marketCap":922209943},{"date":"2022-10-21","current":9.458069,"twenty":3.796195,"median":5.429252,"eighty":9.462795,"marketCap":941030554},{"date":"2022-10-28","current":9.507111,"twenty":3.796195,"median":5.429252,"eighty":9.454174,"marketCap":945909972},{"date":"2022-11-04","current":9.093758,"twenty":3.796195,"median":5.429252,"eighty":9.416144,"marketCap":904783451},{"date":"2022-11-11","current":3.248503,"twenty":3.791136,"median":5.419645,"eighty":9.398806,"marketCap":950446979},{"date":"2022-11-18","current":3.231807,"twenty":3.779229,"median":5.41221,"eighty":9.375567,"marketCap":945562156},{"date":"2022-11-25","current":3.110167,"twenty":3.76699,"median":5.399413,"eighty":9.361853,"marketCap":909972732},{"date":"2022-12-02","current":3.16741,"twenty":3.7586,"median":5.389907,"eighty":9.33056,"marketCap":926720696},{"date":"2022-12-09","current":3.188875,"twenty":3.755171,"median":5.37765,"eighty":9.296797,"marketCap":933001183},{"date":"2022-12-16","current":3.04577,"twenty":3.73787,"median":5.373157,"eighty":9.268907,"marketCap":891131272},{"date":"2022-12-23","current":3.157869,"twenty":3.721737,"median":5.370871,"eighty":9.219774,"marketCap":923929369},{"date":"2022-12-30","current":3.160254,"twenty":3.712352,"median":5.36017,"eighty":9.204798,"marketCap":924627201},{"date":"2023-01-06","current":3.200801,"twenty":3.701355,"median":5.352735,"eighty":9.167406,"marketCap":936490342},{"date":"2023-01-13","current":3.188875,"twenty":3.692734,"median":5.333088,"eighty":9.128427,"marketCap":933001183},{"date":"2023-01-20","current":3.105397,"twenty":3.690153,"median":5.329081,"eighty":9.105671,"marketCap":908577068},{"date":"2023-01-27","current":3.026689,"twenty":3.683733,"median":5.3133,"eighty":9.078668,"marketCap":885548617},{"date":"2023-02-03","current":3.052925,"twenty":3.660478,"median":5.29997,"eighty":9.014694,"marketCap":893224768},{"date":"2023-02-10","current":2.92413,"twenty":3.653686,"median":5.287269,"eighty":8.978083,"marketCap":855541848},{"date":"2023-02-17","current":2.962291,"twenty":3.648628,"median":5.276993,"eighty":8.933954,"marketCap":866707157},{"date":"2023-02-24","current":2.866887,"twenty":3.638752,"median":5.254827,"eighty":8.904325,"marketCap":838793883},{"date":"2023-03-03","current":3.499917,"twenty":3.631691,"median":5.232918,"eighty":8.868252,"marketCap":748705718},{"date":"2023-03-10","current":3.436224,"twenty":3.621445,"median":5.215864,"eighty":8.835303,"marketCap":735080500},{"date":"2023-03-17","current":3.560425,"twenty":3.618049,"median":5.200863,"eighty":8.793592,"marketCap":761649675},{"date":"2023-03-24","current":3.614564,"twenty":3.609038,"median":5.188804,"eighty":8.750715,"marketCap":773231110},{"date":"2023-03-31","current":3.582717,"twenty":3.603966,"median":5.181688,"eighty":8.730663,"marketCap":766418501},{"date":"2023-04-06","current":3.700549,"twenty":3.603459,"median":5.166475,"eighty":8.69652,"marketCap":791625154},{"date":"2023-04-14","current":3.885258,"twenty":3.602952,"median":5.156788,"eighty":8.674168,"marketCap":831138285},{"date":"2023-04-21","current":3.770611,"twenty":3.602952,"median":5.144341,"eighty":8.639328,"marketCap":806612893},{"date":"2023-04-28","current":3.78335,"twenty":3.602952,"median":5.131002,"eighty":8.607948,"marketCap":809337937},{"date":"2023-05-05","current":3.564265,"twenty":3.59758,"median":5.112713,"eighty":8.591234,"marketCap":762471029},{"date":"2023-05-12","current":3.494309,"twenty":3.592693,"median":5.087608,"eighty":8.556531,"marketCap":814219493},{"date":"2023-05-19","current":3.710771,"twenty":3.591527,"median":5.071127,"eighty":8.536736,"marketCap":864657868},{"date":"2023-05-26","current":3.691093,"twenty":3.591527,"median":5.064054,"eighty":8.482623,"marketCap":860072561},{"date":"2023-06-02","current":3.68547,"twenty":3.591527,"median":5.048603,"eighty":8.459414,"marketCap":858762474},{"date":"2023-06-09","current":3.856953,"twenty":3.591527,"median":5.028738,"eighty":8.411843,"marketCap":898720148},{"date":"2023-06-16","current":3.702337,"twenty":3.591379,"median":5.018866,"eighty":8.377115,"marketCap":862692737},{"date":"2023-06-23","current":3.626435,"twenty":3.591083,"median":5.009226,"eighty":8.316656,"marketCap":845006553},{"date":"2023-06-30","current":3.584267,"twenty":3.588457,"median":4.997281,"eighty":8.273434,"marketCap":835180896},{"date":"2023-07-06","current":3.502743,"twenty":3.585402,"median":4.984566,"eighty":8.205703,"marketCap":816184624},{"date":"2023-07-14","current":3.502743,"twenty":3.582717,"median":4.97316,"eighty":8.092774,"marketCap":816184624},{"date":"2023-07-21","current":3.553344,"twenty":3.578604,"median":4.960924,"eighty":7.943882,"marketCap":827975413},{"date":"2023-07-24","current":3.646114,"twenty":3.578604,"median":4.951555,"eighty":7.851265,"marketCap":849591860},{"date":"2023-08-04","current":3.676782,"twenty":3.578604,"median":4.920901,"eighty":7.690116,"marketCap":857991903},{"date":"2023-08-11","current":3.796738,"twenty":3.578604,"median":4.878742,"eighty":7.636489,"marketCap":885984052},{"date":"2023-08-18","current":3.78558,"twenty":3.578604,"median":4.851698,"eighty":7.588225,"marketCap":883380131},{"date":"2023-08-25","current":3.70189,"twenty":3.578604,"median":4.810688,"eighty":7.51851,"marketCap":863850725},{"date":"2023-09-01","current":3.556827,"twenty":3.576513,"median":4.77312,"eighty":7.491696,"marketCap":829999755},{"date":"2023-09-08","current":3.492664,"twenty":3.575345,"median":4.737931,"eighty":7.464883,"marketCap":815027210},{"date":"2023-09-15","current":3.565196,"twenty":3.568459,"median":4.699861,"eighty":7.442002,"marketCap":831952695},{"date":"2023-09-22","current":3.607041,"twenty":3.565196,"median":4.672499,"eighty":7.427344,"marketCap":841717398},{"date":"2023-09-29","current":3.690731,"twenty":3.565196,"median":4.651074,"eighty":7.40053,"marketCap":861246804},{"date":"2023-10-05","current":3.654465,"twenty":3.565196,"median":4.62178,"eighty":7.325453,"marketCap":852784062},{"date":"2023-10-13","current":3.732576,"twenty":3.565158,"median":4.577072,"eighty":7.277188,"marketCap":871011507},{"date":"2023-10-19","current":3.640517,"twenty":3.565138,"median":4.547791,"eighty":7.210691,"marketCap":849529161},{"date":"2023-10-27","current":3.503823,"twenty":3.564003,"median":4.517808,"eighty":7.142836,"marketCap":817631131},{"date":"2023-11-03","current":17.063397,"twenty":3.561951,"median":4.504077,"eighty":7.079305,"marketCap":851071044},{"date":"2023-11-10","current":17.320376,"twenty":3.561951,"median":4.504077,"eighty":7.079305,"marketCap":863888379},{"date":"2023-11-17","current":17.538808,"twenty":3.561951,"median":4.504077,"eighty":7.079305,"marketCap":874783113},{"date":"2023-11-24","current":17.847182,"twenty":3.561951,"median":4.504077,"eighty":7.079305,"marketCap":890163915},{"date":"2023-12-01","current":17.795787,"twenty":3.561951,"median":4.504077,"eighty":7.079305,"marketCap":887600448},{"date":"2023-12-08","current":18.96504,"twenty":3.562009,"median":4.505701,"eighty":7.088421,"marketCap":945919323},{"date":"2023-12-15","current":19.761675,"twenty":3.562009,"median":4.505701,"eighty":7.088421,"marketCap":985653061},{"date":"2023-12-22","current":20.828137,"twenty":3.562009,"median":4.505701,"eighty":7.088421,"marketCap":1038845001},{"date":"2023-12-27","current":20.905231,"twenty":3.562009,"median":4.505701,"eighty":7.088421,"marketCap":1042690202},{"date":"2024-01-05","current":21.560527,"twenty":3.561836,"median":4.503999,"eighty":7.027752,"marketCap":1075374406},{"date":"2024-01-12","current":21.085116,"twenty":3.561836,"median":4.503999,"eighty":7.027752,"marketCap":1051662336},{"date":"2024-01-19","current":20.622554,"twenty":3.561778,"median":4.49256,"eighty":7.016745,"marketCap":1028591133},{"date":"2024-01-26","current":21.226454,"twenty":3.561836,"median":4.503999,"eighty":7.027752,"marketCap":1058711871},{"date":"2024-02-02","current":20.930929,"twenty":3.561836,"median":4.503999,"eighty":7.027752,"marketCap":1043971935},{"date":"2024-02-09","current":20.044352,"twenty":3.561836,"median":4.513774,"eighty":7.101292,"marketCap":999752130},{"date":"2024-02-16","current":20.558309,"twenty":3.561836,"median":4.547791,"eighty":7.207473,"marketCap":1025386800},{"date":"2024-02-23","current":19.890164,"twenty":3.561836,"median":4.587818,"eighty":7.231069,"marketCap":992061729},{"date":"2024-03-01","current":5.448662,"twenty":3.561894,"median":4.62178,"eighty":7.292204,"marketCap":979244394},{"date":"2024-03-08","current":5.305239,"twenty":3.561894,"median":4.661024,"eighty":7.292204,"marketCap":953468181},{"date":"2024-03-15","current":5.178589,"twenty":3.561894,"median":4.674502,"eighty":7.292204,"marketCap":930706341},{"date":"2024-03-22","current":5.273577,"twenty":3.561894,"median":4.702535,"eighty":7.292204,"marketCap":947777721},{"date":"2024-03-28","current":5.379118,"twenty":3.563872,"median":4.737931,"eighty":7.292204,"marketCap":966745921},{"date":"2024-04-05","current":5.15748,"twenty":3.564451,"median":4.784027,"eighty":7.295421,"marketCap":926912701},{"date":"2024-04-12","current":5.175071,"twenty":3.564451,"median":4.820187,"eighty":7.295421,"marketCap":930074068},{"date":"2024-04-19","current":5.168035,"twenty":3.568459,"median":4.852978,"eighty":7.295421,"marketCap":928809521},{"date":"2024-04-26","current":5.273577,"twenty":3.576068,"median":4.884521,"eighty":7.292204,"marketCap":947777721},{"date":"2024-05-03","current":5.346639,"twenty":3.577349,"median":4.923818,"eighty":7.292204,"marketCap":960908730},{"date":"2024-05-10","current":5.26993,"twenty":3.577349,"median":4.944323,"eighty":7.292204,"marketCap":955907253},{"date":"2024-05-17","current":5.501257,"twenty":3.577349,"median":4.972084,"eighty":7.292204,"marketCap":997867552},{"date":"2024-05-24","current":5.435848,"twenty":3.577349,"median":4.980068,"eighty":7.292204,"marketCap":986003044},{"date":"2024-05-31","current":5.284374,"twenty":3.578976,"median":4.999541,"eighty":7.292204,"marketCap":958527342},{"date":"2024-06-07","current":5.635518,"twenty":3.582717,"median":5.011302,"eighty":7.292204,"marketCap":1022221015},{"date":"2024-06-14","current":5.5047,"twenty":3.586773,"median":5.024798,"eighty":7.295421,"marketCap":998492000},{"date":"2024-06-21","current":5.532241,"twenty":3.589018,"median":5.033735,"eighty":7.298639,"marketCap":1003487582},{"date":"2024-06-28","current":5.576994,"twenty":3.589408,"median":5.048603,"eighty":7.301857,"marketCap":1011605403},{"date":"2024-07-05","current":5.621748,"twenty":3.589408,"median":5.064054,"eighty":7.301857,"marketCap":1019723224},{"date":"2024-07-12","current":5.773222,"twenty":3.591379,"median":5.069575,"eighty":7.301857,"marketCap":1047198927},{"date":"2024-07-15","current":5.759451,"twenty":3.594273,"median":5.071127,"eighty":7.301857,"marketCap":1044701135},{"date":"2024-08-02","current":8.298703,"twenty":3.617753,"median":5.091658,"eighty":7.336178,"marketCap":1206830528},{"date":"2024-08-09","current":7.851287,"twenty":3.625972,"median":5.114717,"eighty":7.405997,"marketCap":1141765533},{"date":"2024-08-16","current":7.92012,"twenty":3.63145,"median":5.130178,"eighty":7.433779,"marketCap":1151775532},{"date":"2024-08-23","current":8.019068,"twenty":3.642748,"median":5.141948,"eighty":7.45523,"marketCap":1166164906},{"date":"2024-08-30","current":8.216963,"twenty":3.653491,"median":5.148915,"eighty":7.487406,"marketCap":1194943654},{"date":"2024-09-06","current":8.350328,"twenty":3.670087,"median":5.157134,"eighty":7.502422,"marketCap":1214338027},{"date":"2024-09-13","current":8.436369,"twenty":3.676298,"median":5.163293,"eighty":7.577349,"marketCap":1226850526},{"date":"2024-09-20","current":8.462181,"twenty":3.690086,"median":5.171553,"eighty":7.606458,"marketCap":1230604276},{"date":"2024-09-27","current":8.14813,"twenty":3.692332,"median":5.181495,"eighty":7.668665,"marketCap":1184933655},{"date":"2024-10-04","current":8.389046,"twenty":3.69637,"median":5.18682,"eighty":7.75512,"marketCap":1219968652},{"date":"2024-10-11","current":8.384744,"twenty":3.702248,"median":5.197757,"eighty":7.813325,"marketCap":1219343027},{"date":"2024-10-18","current":8.677285,"twenty":3.710669,"median":5.204902,"eighty":7.881401,"marketCap":1261885524},{"date":"2024-10-25","current":8.518108,"twenty":3.715796,"median":5.212966,"eighty":7.941415,"marketCap":1238737401},{"date":"2024-10-31","current":8.47939,"twenty":3.724703,"median":5.225371,"eighty":7.980349,"marketCap":1233106776},{"date":"2024-11-08","current":19.38384,"twenty":3.738799,"median":5.234878,"eighty":8.063603,"marketCap":1252021620},{"date":"2024-11-15","current":18.647254,"twenty":3.755218,"median":5.252468,"eighty":8.134453,"marketCap":1204444798},{"date":"2024-11-22","current":18.4728,"twenty":3.757873,"median":5.264972,"eighty":8.162272,"marketCap":1193176603},{"date":"2024-11-29","current":18.404956,"twenty":3.761135,"median":5.273577,"eighty":8.218684,"marketCap":1188794528},{"date":"2024-12-06","current":18.337113,"twenty":3.76629,"median":5.280999,"eighty":8.27455,"marketCap":1184412452},{"date":"2024-12-13","current":17.978512,"twenty":3.772706,"median":5.287503,"eighty":8.30802,"marketCap":1161250052},{"date":"2024-12-20","current":17.377613,"twenty":3.775845,"median":5.297939,"eighty":8.332259,"marketCap":1122437382},{"date":"2024-12-27","current":17.106239,"twenty":3.775845,"median":5.308757,"eighty":8.365871,"marketCap":1104909079},{"date":"2025-01-03","current":16.863941,"twenty":3.778884,"median":5.313054,"eighty":8.386465,"marketCap":1089258809},{"date":"2025-01-10","current":16.776714,"twenty":3.785487,"median":5.325718,"eighty":8.394256,"marketCap":1083624712},{"date":"2025-01-17","current":17.881593,"twenty":3.78558,"median":5.332774,"eighty":8.438975,"marketCap":1154989944},{"date":"2025-01-24","current":17.997896,"twenty":3.78558,"median":5.338757,"eighty":8.461325,"marketCap":1162502074},{"date":"2025-01-31","current":18.317729,"twenty":3.788922,"median":5.349748,"eighty":8.487134,"marketCap":1183160430},{"date":"2025-02-07","current":17.697446,"twenty":3.794072,"median":5.352928,"eighty":8.518108,"marketCap":1143095739},{"date":"2025-02-14","current":17.658678,"twenty":3.794072,"median":5.352928,"eighty":8.518108,"marketCap":1140591695},{"date":"2025-02-21","current":17.5133,"twenty":3.794072,"median":5.352928,"eighty":8.518108,"marketCap":1131201533},{"date":"2025-02-28","current":47.022735,"twenty":3.794072,"median":5.352928,"eighty":8.518108,"marketCap":1099955814},{"date":"2025-03-07","current":47.129909,"twenty":3.793184,"median":5.352735,"eighty":8.515527,"marketCap":1102462836},{"date":"2025-03-14","current":46.594038,"twenty":3.793184,"median":5.352735,"eighty":8.536093,"marketCap":1089927727},{"date":"2025-03-21","current":46.111753,"twenty":3.793184,"median":5.353122,"eighty":8.555967,"marketCap":1078646129},{"date":"2025-03-28","current":47.906923,"twenty":3.793184,"median":5.353122,"eighty":8.573144,"marketCap":1120638744},{"date":"2025-04-04","current":48.442795,"twenty":3.793184,"median":5.353122,"eighty":8.676508,"marketCap":1133173853},{"date":"2025-04-11","current":45.817024,"twenty":3.794072,"median":5.353676,"eighty":8.711262,"marketCap":1071751819},{"date":"2025-04-17","current":48.469588,"twenty":3.794072,"median":5.353676,"eighty":8.786896,"marketCap":1133800609},{"date":"2025-04-25","current":49.321723,"twenty":3.793184,"median":5.353122,"eighty":9.089554,"marketCap":1153733755},{"date":"2025-05-02","current":50.046254,"twenty":3.793184,"median":5.353122,"eighty":9.161016,"marketCap":1170681966},{"date":"2025-05-09","current":-19.529213,"twenty":3.785799,"median":5.350974,"eighty":9.242284,"marketCap":1166362714},{"date":"2025-05-16","current":-19.266441,"twenty":3.780033,"median":5.341102,"eighty":9.242284,"marketCap":1150668921},{"date":"2025-05-23","current":-19.781474,"twenty":3.767718,"median":5.333088,"eighty":9.242284,"marketCap":1181428755},{"date":"2025-05-30","current":-20.485703,"twenty":3.762308,"median":5.329081,"eighty":9.242284,"marketCap":1223488121},{"date":"2025-06-06","current":-22.251531,"twenty":3.756175,"median":5.3133,"eighty":9.242284,"marketCap":1328950412},{"date":"2025-06-13","current":-22.493281,"twenty":3.746652,"median":5.308757,"eighty":9.242284,"marketCap":1343388702},{"date":"2025-06-20","current":-22.556346,"twenty":3.728267,"median":5.297483,"eighty":9.247889,"marketCap":1347155212},{"date":"2025-06-27","current":-21.431682,"twenty":3.715923,"median":5.287386,"eighty":9.247889,"marketCap":1279985777},{"date":"2025-07-03","current":-20.191398,"twenty":3.710771,"median":5.282687,"eighty":9.247889,"marketCap":1205911073},{"date":"2025-07-11","current":-20.033735,"twenty":3.702337,"median":5.273644,"eighty":9.247889,"marketCap":1196494797},{"date":"2025-07-18","current":-20.895627,"twenty":3.69631,"median":5.262238,"eighty":9.247889,"marketCap":1247970439},{"date":"2025-07-25","current":-19.886583,"twenty":3.691093,"median":5.251388,"eighty":9.247889,"marketCap":1187706273},{"date":"2025-07-28","current":-19.676365,"twenty":3.690731,"median":5.250308,"eighty":9.247889,"marketCap":1175151238}],"updateTime":1753852716291}}}